501 Graham Rd.

College Station, TX 77845

  • Grey LinkedIn Icon

© 2019

Bondwell Technologies Inc

Team

David W. Howell, MS, PhD

President and CEO

Dr. Howell is a co-founder of the company and leads all business and commercial activities while overseeing R&D in the lab. He earned a BA in Biology from Texas A&M University, a MS in Neurobiology from UTSA, and a PhD in Medical Science (focused on mechanical and genetic factors of thoracic aortic aneurysm progression) from Texas A&M Health Science Center.  He completed his training in Tissue Engineering as a post-doctoral research associate in Dr. Bondos lab, where he authored 6 papers.

Sarah E. Bondos, PhD

CSO

Dr. Bondos, an Associate Professor at Texas A&M Health Science Center, discovered our protein-based materials. She is an editor for the journal Intrinsically Disordered Proteins, has been elected to multiple offices in the Biophysical Society, and has organized several national research meetings. She  has won several awards related to her research, including an NSF CAREER Award and a TAMHSC College of Medicine Research Excellence Award.

Kristin A. Howell, CPA

CFO

Ms. Howell was an auditor and licensed CPA for KPMG before becoming a Senior Academic Advisor in the Professional Program in the Accounting department at Texas A&M University. She has also taught CPA review courses and served as a volunteer for many community groups. 

Kenith Meissner, PhD

Director of Manufacturing and Automation

Dr. Kenith Meissner is a professor and chair at the Centre for NanoHealth at Swansea University, UK. His research combines materials development with expertise in optical system design for biomedical imaging and sensing applications. Dr. Meissner has developed a process to automate our material assembly process and begun optimization of large-scale material production.

Lauren Kustigian, PhD

Postdoctoral Research Associate

Dr. Lauren Kustigian recently earned a Ph.D. in protein biochemistry from Texas A&M University. Prior to earning a Ph.D., Dr. Kustigian spent 6 years in the pharmaceutical industry at both Sirtris Pharmaceuticals and Microbiotix. Dr. Kustigian is an accomplished biochemist with experience in protein chemistry and enzyme kinetics.

Advisory Board

Maik W. Jornitz

CEO of G-Con Manufacturing

Mr. Jornitz has >30 years of experience in bioprocessing, including 25 years at Sartorius Stedim with final position of Senior Vice President, Marketing & Product Management. He is currently Chair of the Parenteral Drug Association (PDA) Science Advisory Board, where he trains members of the industry and regulatory authorities. He was recently recognized as one of the top ten global industry influencers. Mr. Jornitz has been awarded 30 patents. In addition to his current role as CEO of G-Con, Maik is the founder and principal consultant of BioProcess Resources.

Brenton Scott, PhD, MBA

President and COO of Pulmotect

Dr. Scott is a co-founder of the company and has helped lead the initial technology out of the lab and into the clinic. Prior to his industry role, his academic experience focused on vesicular traffic, airway inflammation and infection. He serves as the PI on multiple grant awards, including the Cancer Prevention Research Institute of Texas (CPRIT) and Texas Emerging Technology Fund (TETF) awards from the State of Texas and seven Small Business Innovative Research (SBIR) awards. He is a regular reviewer of SBIR grant applications for the NIH. He concurrently received his PhD in Biochemistry and Cell Biology from Rice University and his MBA from University of Houston.

James Y. Lancaster, MBA

Texas Branch Manager at VIC TVD and CEO for Solenic Medical & Tesseract Structural Innovations

Mr. Lancaster has co-founded 12 technology companies in addition to the Innovate family companies, which include Innovate CXO Services, Innovate Angel Funds and Innovate BCS Development. His companies were funded by bootstrapping, angel investors and venture capital, and include both positive exits and ongoing growth stage companies. He advises entrepreneurs and early-stage companies. Mr. Lancaster previously served as CEO and Chairman of Shape Memory Therapeutics, Inc., and currently serves on the boards of Ecolyse and the non-profit BrightMinds Foundation.

Garrett Blundell, DDS, MD

Maxiofacial Surgeon and CEO fo Sympliact

Dr. Blundell is an Oral & Maxillofacial Surgeon in Bryan-College Station, Texas.  He has also operated as a founding and managing member of two start-up companies - HEXA Containment and Sympliact.  HEXA Containment is a manufacturing and service company primarily targeting a niche in the industrial and energy services markets and Sympliact is a software and technology development company targeting the healthcare market.

Peggy Whitson, PhD

Retired NASA Astronaut and Biochemist

Dr. Whitson is an accomplished astronaut and biochemist with a long list of notable experiences and awards. Highlights include first female Commander on the International Space Station and Chief of the Astronaut Office. Dr. Whitson accrued a total cumulative time in space of 665 days, a current record for any US astronaut and a record for women worldwide. She has performed over 300 scientific investigations aboard the International Space Station and authored 46 peer reviewed journal articles.

Additional Advisors: We are fortunate to have the support of a large group of experts in entrepreneurship and biotechnology commercialization who believe in this technology. Several of these highly successful individuals have become “smart money” investors and also act as personal mentors.